Second, multi-display of tumor-targeting IL4 receptor-binding peptides (IL4rPs) on the surface of the ATNC overcomes the mistargeting of TRAIL caused by dilution through binding to decoy receptors or rapid elimination from the circulation by the kidneys. Here, TNFSF10 is linked to neoplasm.